146 related articles for article (PubMed ID: 24589444)
1. Fragment screening reveals salicylic hydroxamic acid as an inhibitor of Trypanosoma brucei GPI GlcNAc-PI de-N-acetylase.
Urbaniak MD; Capes AS; Crossman A; O'Neill S; Thompson S; Gilbert IH; Ferguson MA
Carbohydr Res; 2014 Mar; 387(100):54-8. PubMed ID: 24589444
[TBL] [Abstract][Full Text] [Related]
2. Inhibitors incorporating zinc-binding groups target the GlcNAc-PI de-N-acetylase in Trypanosoma brucei, the causative agent of African sleeping sickness.
Abdelwahab NZ; Crossman AT; Sullivan L; Ferguson MA; Urbaniak MD
Chem Biol Drug Des; 2012 Mar; 79(3):270-8. PubMed ID: 22222041
[TBL] [Abstract][Full Text] [Related]
3. In silico drug re-purposing against African sleeping sickness using GlcNAc-PI de-N-acetylase as an experimental target.
Rashmi M; Swati D
Comput Biol Chem; 2015 Dec; 59 Pt A():87-94. PubMed ID: 26476127
[TBL] [Abstract][Full Text] [Related]
4. Cloning of Trypanosoma brucei and Leishmania major genes encoding the GlcNAc-phosphatidylinositol de-N-acetylase of glycosylphosphatidylinositol biosynthesis that is essential to the African sleeping sickness parasite.
Chang T; Milne KG; Güther ML; Smith TK; Ferguson MA
J Biol Chem; 2002 Dec; 277(51):50176-82. PubMed ID: 12364327
[TBL] [Abstract][Full Text] [Related]
5. Probing the substrate specificity of Trypanosoma brucei GlcNAc-PI de-N-acetylase with synthetic substrate analogues.
Capes AS; Crossman A; Urbaniak MD; Gilbert SH; Ferguson MA; Gilbert IH
Org Biomol Chem; 2014 Mar; 12(12):1919-34. PubMed ID: 24519084
[TBL] [Abstract][Full Text] [Related]
6. Differences between the trypanosomal and human GlcNAc-PI de-N-acetylases of glycosylphosphatidylinositol membrane anchor biosynthesis.
Sharma DK; Smith TK; Weller CT; Crossman A; Brimacombe JS; Ferguson MA
Glycobiology; 1999 Apr; 9(4):415-22. PubMed ID: 10089216
[TBL] [Abstract][Full Text] [Related]
7. The N-acetyl-D-glucosaminylphosphatidylinositol De-N-acetylase of glycosylphosphatidylinositol biosynthesis is a zinc metalloenzyme.
Urbaniak MD; Crossman A; Chang T; Smith TK; van Aalten DM; Ferguson MA
J Biol Chem; 2005 Jun; 280(24):22831-8. PubMed ID: 15817455
[TBL] [Abstract][Full Text] [Related]
8. Specificity of GlcNAc-PI de-N-acetylase of GPI biosynthesis and synthesis of parasite-specific suicide substrate inhibitors.
Smith TK; Crossman A; Borissow CN; Paterson MJ; Dix A; Brimacombe JS; Ferguson MA
EMBO J; 2001 Jul; 20(13):3322-32. PubMed ID: 11432820
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of potential metal-binding group compounds to examine the zinc dependency of the GPI de-N-acetylase metalloenzyme in Trypanosoma brucei.
Abdelwahab NZ; Urbaniak MD; Ferguson MA; Crossman AT
Carbohydr Res; 2011 May; 346(6):708-14. PubMed ID: 21377660
[TBL] [Abstract][Full Text] [Related]
10. Substrate specificity of the N-acetylglucosaminyl-phosphatidylinositol de-N-acetylase of glycosylphosphatidylinositol membrane anchor biosynthesis in African trypanosomes and human cells.
Sharma DK; Smith TK; Crossman A; Brimacombe JS; Ferguson MA
Biochem J; 1997 Nov; 328 ( Pt 1)(Pt 1):171-7. PubMed ID: 9359849
[TBL] [Abstract][Full Text] [Related]
11. Partial purification and characterization of the N-acetylglucosaminyl-phosphatidylinositol de-N-acetylase of glycosylphosphatidylinositol anchor biosynthesis in African trypanosomes.
Milne KG; Field RA; Masterson WJ; Cottaz S; Brimacombe JS; Ferguson MA
J Biol Chem; 1994 Jun; 269(23):16403-8. PubMed ID: 8206949
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibitors of the glycosylphosphatidylinositol biosynthetic pathway of Trypanosoma brucei.
Smith TK; Sharma DK; Crossman A; Brimacombe JS; Ferguson MA
EMBO J; 1999 Nov; 18(21):5922-30. PubMed ID: 10545104
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of histone deacetylase inhibitors (HDACi) as therapeutic leads for human African trypanosomiasis (HAT).
Carrillo AK; Guiguemde WA; Guy RK
Bioorg Med Chem; 2015 Aug; 23(16):5151-5. PubMed ID: 25637120
[TBL] [Abstract][Full Text] [Related]
14. Trypanosome glycosylphosphatidylinositol biosynthesis.
Hong Y; Kinoshita T
Korean J Parasitol; 2009 Sep; 47(3):197-204. PubMed ID: 19724691
[TBL] [Abstract][Full Text] [Related]
15. The properties and function of the glycosylphosphatidylinositol-phospholipase C in Trypanosoma brucei.
Carrington M; Carnall N; Crow MS; Gaud A; Redpath MB; Wasunna CL; Webb H
Mol Biochem Parasitol; 1998 Mar; 91(1):153-64. PubMed ID: 9574933
[TBL] [Abstract][Full Text] [Related]
16. Phosphatidylinositol synthesis is essential in bloodstream form Trypanosoma brucei.
Martin KL; Smith TK
Biochem J; 2006 Jun; 396(2):287-95. PubMed ID: 16475982
[TBL] [Abstract][Full Text] [Related]
17. Trypanosome alternative oxidase, a potential therapeutic target for sleeping sickness, is conserved among Trypanosoma brucei subspecies.
Nakamura K; Fujioka S; Fukumoto S; Inoue N; Sakamoto K; Hirata H; Kido Y; Yabu Y; Suzuki T; Watanabe Y; Saimoto H; Akiyama H; Kita K
Parasitol Int; 2010 Dec; 59(4):560-4. PubMed ID: 20688188
[TBL] [Abstract][Full Text] [Related]
18. A novel allosteric inhibitor of the uridine diphosphate N-acetylglucosamine pyrophosphorylase from Trypanosoma brucei.
Urbaniak MD; Collie IT; Fang W; Aristotelous T; Eskilsson S; Raimi OG; Harrison J; Navratilova IH; Frearson JA; van Aalten DM; Ferguson MA
ACS Chem Biol; 2013 Sep; 8(9):1981-7. PubMed ID: 23834437
[TBL] [Abstract][Full Text] [Related]
19. Phosphatidylinositol hydrolysis by Trypanosoma brucei glycosylphosphatidylinositol phospholipase C.
Bütikofer P; Boschung M; Brodbeck U; Menon AK
J Biol Chem; 1996 Jun; 271(26):15533-41. PubMed ID: 8663180
[TBL] [Abstract][Full Text] [Related]
20. Chemical validation of GPI biosynthesis as a drug target against African sleeping sickness.
Smith TK; Crossman A; Brimacombe JS; Ferguson MA
EMBO J; 2004 Nov; 23(23):4701-8. PubMed ID: 15526036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
